FASLODEX Pages on BioPortfolio:

Biotechnology News FASLODEX Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/FASLODEX-news.htm...

BioPortfolio - AstraZeneca - Phase III CONFIRM Study Shows ...
10 Dec 2009 ... fulvestrant (FASLODEX) 500 mg reduced the risk of disease progression ... CONFIRM (COmparisoN of FASLODEX In Recurrent or Metastatic breast ...
http://www.bioportfolio.com/news/Phase-III-CONFIRM-Study-Sho...

BioPortfolio's Approved Drugs News by Tradename - F
Click the link below to view the latest news: FABRAZYME · FACTIVE · FACTREL · FAMCICLOVIR · FAMOTIDINE · FAMVIR · FANSIDAR · FARESTON · FASLODEX ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_n...

BioPortfolio - Faslodex
Faslodex - BioPortfolio - Indepth. ... Faslodex. Fulvestrant. Download PDF containing detailed information. PDF Version ...
http://www.bioportfolio.com/indepth/Faslodex.html...

BioPortfolio.com - BioWeb ALINIA NITAZOXANIDE Search
... Tablet Sankyo- 1S 04-25-2002 21-344 Fulvestrant Faslodex Injection AstraZeneca 1S 04-25-2002 21-272 Treprostinil Sodium Remodulin Injection United.
...
http://www.bioportfolio.co.uk/ALINIA+NITAZOXANIDE-bioweb.htm...

BioPortfolio News: AstraZeneca - Phase III CONFIRM Study Shows...
10 Dec 2009 ... CONFIRM (COmparisoN of FASLODEX In Recurrent or Metastatic breast cancer) ... Two other abstracts for FASLODEX were presented at SABCS 2009: ...
http://www.bioportfolio.com/news/Phase-III-CONFIRM-Study-Sho...

BioPortfolio - Disease Progression - InDepth
AstraZeneca says high dose of Faslodex tops current dose at reducing breast ... Phase III CONFIRM Study Shows Faslodex (fulvestrant) Injection 500 mg May ...
http://www.bioportfolio.com/indepth/Disease_Progression.pdf...

Oncology Market Forecast to 2015 (TA225)
Faslodex (fulvestrant) (AstraZeneca). * Femara (letrozole) (Novartis). * Lupron (leuprolide) (Abbott Labs). * MDV3100 (Astellas, Medivation) ...
http://www.bioportfolio.com/cgi-bin/ss000001.pl?PRODREF=2278...

BioPortfolio Limited Commercial Insight: Antihormonal Therapy ...
Faslodex will experience the greatest number of forecast events across .... Table 63: Faslodex forecast sales in the seven major markets ($m), 2007-2017 146
...
http://www.bioportfolio.com/cgi-bin/acatalog/info_499.html...

The World Market for Cancer Therapeutics and Biotherapeutics, 3rd ...
AstraZeneca (coverage of Arimidex, Casodex, Faslodex, Zoladex, Iressa, Nolvadex and other products). * Biogen IDEC (coverage of Rituxan and other products) ...
http://www.bioportfolio.com/cgi-bin/acatalog/The_World_Marke...

Results from other life science and pharmaceutical sites:

Faslodex (fulvestrant) - breast cancer treatment - AstraZeneca
Faslodex (fulvestrant) information, an estrogen receptor antagonist targeted towards breast cancer treatment; provided by AstraZeneca.
http://www.astrazeneca.com/medicines/?itemId=3887988...

Fulvestrant - Wikipedia, the free encyclopedia
It is administered as a once-monthly injection. Fulvestrant is marketed by AstraZeneca with the brand name Faslodex. ...
http://en.wikipedia.org/wiki/Fulvestrant...

Faslodex (ICI 182780). an oestrogen receptor downregulator.
Faslodex (ICI 182780). an oestrogen receptor downregulator. Howell A. CRC Department of Medical Oncology, Christie Hospital NHS Trust, M20 4BX, Manchester
, ...
http://www.ncbi.nlm.nih.gov/pubmed/11056334...

FASLODEX (fulvestrant) injection [AstraZeneca Pharmaceuticals LP ...
4 Aug 2009 ... FASLODEX® (fulvestrant) Injection for intramuscular administration is an estrogen receptor antagonist without known agonist effects. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=10528...

The pure anti-oestrogen ICI 182780 (Faslodex™) activates large ...
It is unknown whether a 'pure' anti-oestrogen such as ICI 182780 (Faslodex™), that has no known oestrogenic properties, would have any effect on BKCa ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573435/...

Faslodex anyone? - Discussion - Advanced Breast Cancer Support ...
Faslodex was the drug I began after learning of my widespread lungs ... Six months on Faslodex, I began experiencing nausea and was given ...
http://www.inspire.com/groups/advanced-breast-cancer/discuss...

Fulvestrant (Faslodex) versus anastrozole for the second-line ...
The efficacy of fulvestrant (Faslodex), a novel oestrogen receptor (ER) antagonist that downregulates the ER and has no known agonist effects, was
compared ...
http://www.ncbi.nlm.nih.gov/pubmed/12763210...

Faslodex Side Effects: Leg Pain: Any Suggestions? - Discussion ...
She moved from Femara to Faslodex when the former stopped working. But is now suffering terribly--leg pain, cramps--especially later in the ...
http://www.inspire.com/groups/advanced-breast-cancer/discuss...

ICI 182780 (Faslodex): development of a novel, "pure" antiestrogen.
ICI 182780 (Faslodex) from AstraZeneca (Cheshire, United Kingdom) is a novel, steroidal estrogen antagonist that was designed to be devoid of estrogen ...
http://www.ncbi.nlm.nih.gov/pubmed/10951345...

Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection ...
10 Dec 2009 ... Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in ...
http://www.prnewswire.com/news-releases/phase-iii-confirm-st...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.